Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

BACKGROUND: Hyperphosphatemia necessitates the use of phosphate binders in most dialysis patients. Long-term efficacy and tolerability of the iron-based phosphate binder, sucroferric oxyhydroxide (previously known as PA21), was compared with that of sevelamer carbonate (sevelamer) in an open-label P...

Descripción completa

Detalles Bibliográficos
Autores principales: Floege, Jürgen, Covic, Adrian C., Ketteler, Markus, Mann, Johannes F.E., Rastogi, Anjay, Spinowitz, Bruce, Chong, Edward M.F., Gaillard, Sylvain, Lisk, Laura J., Sprague, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438742/
https://www.ncbi.nlm.nih.gov/pubmed/25691681
http://dx.doi.org/10.1093/ndt/gfv006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438742/
https://www.ncbi.nlm.nih.gov/pubmed/25691681
http://dx.doi.org/10.1093/ndt/gfv006

Ejemplares similares